Literature DB >> 22592515

Role of procalcitonin in the diagnosis of severe infection in pediatric patients with fever and Neutropenia--a systemic review and meta-analysis.

Shu-Guang Lin1, Tie-Ying Hou, De-Hong Huang, Shao-Yu Ru He, Yu Deng Lin, Li-Yan Zhang, Pei-Shan Hsieh.   

Abstract

OBJECTIVE: The aim of this study was to determine the accuracy of the procalcitonin (PCT) test for diagnosis of bacterial sepsis in pediatric cancer patients with febrile neutropenia.
METHODS: Three major databases, MEDLINE, EMBASE and the Cochrane Library were searched for studies that evaluated the diagnostic value of PCT alone or compared with other laboratory markers such as C-reactive protein (CRP) to identify bacterial sepsis in children with fever and neutropenia. A bivariate model was used to derive summary sensitivity and specificity of the diagnostic tests.
RESULTS: A total of 10 studies looking into PCT tests and 8 studies looking into CRP tests were included in the final analysis. The prevalence of bacterial sepsis was 304 of 1031 (29.5%) in PCT studies and 741 of 1316 (56.3%) in CRP studies. In terms of area under the receiver operating characteristic curve, PCT had comparable discrimination to CRP (area under the curve: 0.75 versus 0.74). PCT was not as sensitive as the CRP test. The pooled sensitivity of PCT was 0.59 (95% confidence interval [CI]: 0.42-0.74) as compared with 0.75 (95% CI: 0.61-0.85) for CRP. PCT was more specific than sensitive whereas CRP was more sensitive than specific in this population. The pooled specificity was 0.76 (95% CI: 0.64-0.85) for PCT and 0.62 (95% CI: 0.49-0.73) for CRP. PCT had greater likelihood ratio positive (2.50; 95% CI: 1.64-3.81), making it the better rule-in test.
CONCLUSIONS: Of three markers potentially useful for diagnosing bacterial sepsis in children with fever and neutropenia, PCT had comparable diagnostic accuracy to CRP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592515     DOI: 10.1097/INF.0b013e31825da45d

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

Review 1.  Utility of Procalcitonin as a Biomarker for Sepsis in Children.

Authors:  Kevin J Downes; Julie C Fitzgerald; Scott L Weiss
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

2.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.

Authors:  Lidija Kitanovski; Janez Jazbec; Sergej Hojker; Metka Derganc
Journal:  Support Care Cancer       Date:  2013-09-21       Impact factor: 3.603

3.  C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms.

Authors:  Juan F Combariza; Milton Lombana; Luis E Pino; Marcos Arango
Journal:  Support Care Cancer       Date:  2014-10-02       Impact factor: 3.603

Review 4.  Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis.

Authors:  Chun-Wei Wu; Jiunn-Yih Wu; Chun-Kuei Chen; Shiau-Ling Huang; Shou-Chien Hsu; Meng-Tse Gabriel Lee; Shy-Shin Chang; Chien-Chang Lee
Journal:  Support Care Cancer       Date:  2015-02-21       Impact factor: 3.603

5.  Estimating the probability of bacterial infection using a novel biomarker among pediatric patients in the emergency department.

Authors:  Michelle Eckerle; Patrick Lahni; Hector Wong
Journal:  Biomarkers       Date:  2016-05-16       Impact factor: 2.658

6.  Procalcitonin as a Predictive Tool for Death and ICU Admission among Febrile Neutropenic Patients Visiting the Emergency Department.

Authors:  Christopher J Coyne; Edward M Castillo; Rebecca A Shatsky; Theodore C Chan
Journal:  Medicina (Kaunas)       Date:  2022-07-23       Impact factor: 2.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.